Oxycodone Hydrochloride
Product Images NDC 31722-110

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxycodone Hydrochloride (NDC 31722-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

10 mg (10 mg 100s)

10 mg (10 mg 100s)
FDA Label Image

20 mg (20 mg 100s)

20 mg (20 mg 100s)
FDA Label Image

40 mg (40 mg 100s)

40 mg (40 mg 100s)
FDA Label Image

Figure 1 (Fig 1)

Figure 1 (Fig 1)
The provided text is a table that shows the percentage of subjects for "Drug Liking" in "Finely Crushed Oxycodone HCI Extended-Release Tablets" versus "Powdered Oxycodone HCI" after intranasal administration. The table has columns labeled "W", "w0", "M", and "Percent Reduction", with a row of percentages beneath them. The last row shows a percent reduction of 100. No further information is available.*
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Table 6 (Table 6)

Table 6 (Table 6)
This text appears to be a table presenting mean values of different doses for a certain substance, possibly a medication, along with some statistical values. The substance appears to be administered through different dosages and forms, such as in "SingleDosef" and "20mg". The last line mentions "naltrexons" and "absorption". Without more context, it is difficult to determine the exact nature of this substance or the purpose of this table.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.